Continued Anticonvulsants After Resolution of Neonatal Seizures: a

Updated 06/21/2024

Status Completed

Clinical Trial Summary

The purpose of this study is to examine whether the duration of treatment with phenobarbital has an impact on neurodevelopmental and epilepsy outcomes, as well as parent and family well-being, after neonatal seizures.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02789176
Study type	Observational
Source	University of Michigan
Contact
Status	Completed
Phase
Start date	October 2016
Completion date	March 24, 2020

See also
	Status	Clinical Trial	Phase
	Terminated	`NCT01089504` - Prophylactic Phenobarbital After Neonatal Seizures	Phase 4
	Terminated	`NCT02550028` - Levetiracetam Treatment of Neonatal Seizures	Phase 1/Phase 2
	Not yet recruiting	`NCT02602015` - Levetiracetam Treatment of Neonatal Seizures	Phase 1/Phase 2
	Terminated	`NCT01475656` - Efficacy of Keppra for Neonatal Seizures	N/A
	Recruiting	`NCT03107507` - Efficacy of Levetiracetam in Control of Neonatal Seizures Guided by an EEG	Phase 4
	Completed	`NCT01720667` - Efficacy of Intravenous Levetiracetam in Neonatal Seizures	Phase 1/Phase 2
	Recruiting	`NCT05079971` - EAGLET: EEG vs aEEG to Improve the Diagnosis of neonataL Seizures and Epilepsy	N/A
	Completed	`NCT02229123` - Levetiracetam Treatment of Neonatal Seizures: Safety and Efficacy Phase II Study	Phase 2
	Completed	`NCT01434225` - NEMO1:NEonatal Seizure Using Medication Off-patent	Phase 1/Phase 2
	Completed	`NCT02160171` - ANSeR- The Algorithm for Neonatal Seizure Recognition Study	N/A